GENE
Genetic Technologies Ltd.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
genetic technologies (asx: gtg, nasdaq global market: gene) is leading-edge genetic testing and reproductive services business which, together with an extensive range of international patents and allied research activities, aims at uncovering the impact of dna on health. throughout the asia pacific region, we translate specialised genetic tests into products and services that optimise the health knowledge and outcomes in humans, animals and plants.
Market Cap: 11.1 Million
Primary Exchange: NASDAQ
Website: https://www.gtglabs.com/
Shares Outstanding: 3.85 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.8065803892691796
Sector: Professional, Scientific, and Technical Services
Industry: Testing Laboratories
Ethical Flags
Longest drawdown: 4323 trading days
From: 2013-05-20 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2015-01-20 | 5.0 | 1.0 | 5.0 |